Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-17-002757
Filing Date
2017-08-17
Accepted
2017-08-17 19:44:54
Documents
1
Period of Report
2017-08-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 13600
  Complete submission text file 0001562180-17-002757.txt   14997
Mailing Address C/O DERMIRA, INC. 275 MIDDLEFIELD ROAD, SUITE 150 MENLO PARK CA 94025
Business Address
BAUER EUGENE A (Reporting) CIK: 0001210524 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36668 | Film No.: 171039909

Mailing Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025
Business Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025 650 421 7200
Dermira, Inc. (Issuer) CIK: 0001557883 (see all company filings)

EIN.: 273267680 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations